News Cellectis S.A.

Equities

ALCLS

FR0010425595

Market Closed - Euronext Paris Other stock markets 11:35:22 2024-06-07 am EDT			5-day change	1st Jan Change
2.36 ^EUR	0.00%		-2.07%	-14.62%

Jun. 07	European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading	MT
Jun. 06	Tech Firms Lead European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading	Jun. 07	MT
Tech Firms Lead European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading	Jun. 06	MT
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading	Jun. 05	MT
Cellectis: orphan drug designation in ALL	Jun. 05	CF
Cellectis S A : Receives Orphan Drug Designation for UCART22, its Allogeneic CAR T Product for Patients with Acute Lymphoblastic Leukemia	Jun. 04	PU
Cellectis Gets Orphan Drug Label From European Commission For Acute Lymphoblastic Leukemia	Jun. 04	MT
Cellectis Receives Orphan Drug Designation for UCART22, its Allogeneic CAR T Product for Patients with Acute Lymphoblastic Leukemia	Jun. 04	GL
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading	Jun. 04	MT
Cellectis S A : Environmental Social & Governance Report - March 2024	Jun. 04	PU
European Equities Traded in US as American Depositary Receipts Rise Friday, Poised to End Week Lower	May. 31	MT
Cellectis’ Annual Shareholders General Meeting to be Held on June 28, 2024	May. 29	GL
European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Wednesday Trading	May. 29	MT
Transcript : Cellectis S.A., Q1 2024 Earnings Call, May 29, 2024	May. 29
Cellectis: operations financed until 2026	May. 29	CF
Cellectis S A : Corporate Presentation - May 2024	May. 28	PU
Earnings Flash (CLLS) CELLECTIS Posts Q1 Revenue $6.5M	May. 28	MT
Cellectis Reports Financial Results for First Quarter 2024	May. 28	GL
Cellectis Reports Financial Results for First Quarter 2024	May. 28	AQ
Cellectis S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 28	CI
European Equities Traded in the US as American Depositary Receipts Open Week Lower in Tuesday Trading	May. 28	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Cellectis S.A.

Equities

ALCLS

FR0010425595

Summary

Filters